229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
View analysts' price targets and recommendations, and compare them with competitors.
$228.20
Analysts expect the stock price to decrease by 2.51%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
430.41B
Revenue has increased from the previous period.
10.07%
Revenue growth rate has increased from the previous period.
141.35B
EBITDA has increased from the previous period.
32.84%
EBITDA margin has decreased from the previous period.
127.69B
EBIT has increased from the previous period.
29.67%
EBIT margin has decreased from the previous period.
13.65B
Depreciation has increased from the previous period.
81.97B
Total cash has increased from the previous period.
19.05%
Cash percentage has increased from the previous period.
65.44B
Receivables have decreased from the previous period.
15.20%
Receivables percentage has decreased from the previous period.
6.93B
Inventories have decreased from the previous period.
1.61%
Inventory percentage has decreased from the previous period.
69.39B
Accounts payable has increased from the previous period.
16.12%
Payables percentage has decreased from the previous period.
-11.78B
Capital expenditure has increased from the previous period.
-2.74%
CapEx percentage has increased from the previous period.
8.68%
WACC has decreased from the previous period.
8.86%
Cost of equity has decreased from the previous period.
3.63%
Cost of debt has decreased from the previous period.
1.11
Beta has decreased from the previous period.
15.41B
Diluted shares outstanding is unchanged from the previous period.
119.06B
Total debt has increased from the previous period.
3.61T
Total equity has decreased from the previous period.
3.73T
Total capital has decreased from the previous period.
3.20%
Debt weighting has increased from the previous period.
96.80%
Equity weighting has decreased from the previous period.
106.56B
EBIAT has increased from the previous period.
110.02B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.53T
Terminal value has increased from the previous period.
2.84T
Enterprise value has increased from the previous period.
89.12B
Net debt has increased from the previous period.
2.75T
Equity value has increased from the previous period.
178.56
Equity value per share has increased from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
264.52B
The estimated revenue has increased from the previous period.
81.92B
The estimated EBITDA has increased from the previous period.
2.94
The estimated EPS has increased from the previous period.
57.48B
The estimated net income has increased from the previous period.
65.77B
The estimated EBIT has increased from the previous period.
16.64B
The estimated SG&A expenses have increased from the previous period.
